Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
09/2002
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451827 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
09/17/2002US6451824 Sulfonylaminocarboxylic acids
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451801 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451736 Substituted aromatic thiocarboxylic acid amides and their use as herbicides
09/17/2002US6451724 Bis(n-methyl-5,10-dihydroindeno(1,2-b)indol-10 -yl)titanium dichloride
09/12/2002WO2002071718A2 A method and system for a low-overhead mobility management protocol in the internet protocol layer
09/12/2002WO2002070624A1 Photochromic material
09/12/2002WO2002070541A2 Peptide deformylase inhibitors
09/12/2002WO2002070516A2 Cyclopropaheterocycles as non-nucleoside reverse transcriptase inhibitors
09/12/2002WO2002070501A1 Preparation of phthalanes
09/12/2002WO2002070500A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
09/12/2002WO2002070499A2 Prodrugs derivatives of the ascorbic acid suitable to the passage of the hematoencephalic barrier
09/12/2002WO2002070492A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
09/12/2002WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy
09/12/2002WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
09/12/2002WO2002070128A1 Improved method for producing unsaturated cyclic ethers
09/12/2002WO2002069901A2 Cathepsin cysteine protease inhibitors
09/12/2002WO2002053099A3 Methods and compositions for treating periodontal disease
09/12/2002US20020128506 Catalytic oxidation of alcohols using manganese oxides
09/12/2002US20020128497 Method for the preparation of citalopram
09/12/2002US20020128491 Catalytically coupling an aryl aldehyde or aryl C(=S)H with thione or ketone compound to form diaryl substituted dithione or diketone intermediate, treating intermediate with reducing agent, and cyclizing and isomerizing
09/12/2002US20020128434 Alpha-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors
09/12/2002US20020128315 Amidinophenol derivatives as leukotriene B4 (LTB4)antagonists, phospholipase A2 inhibitors, and trypsin inhibitors.
09/12/2002US20020128301 Non-nucleoside reverse transcriptase inhibitors
09/12/2002US20020128294 Nicotine in therapeutic angiogenesis and vasculogenesis
09/12/2002US20020128290 Derivatives of benzofuran or benzodioxole
09/12/2002US20020128267 Especially celecoxib, deracoxib, valdecoxib, a benzopyran COX-2 inhibitor, parecoxib, rofecoxib etoricoxib, or a 2-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl) -substituted cyclopentenone, or pyridazinone
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002CA2704835A1 A method and system for a low-overhead mobility management protocol in the internet protocol layer
09/12/2002CA2442613A1 Preparation of phthalanes
09/12/2002CA2440104A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
09/12/2002CA2439827A1 Peptide deformylase inhibitors
09/12/2002CA2438737A1 Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derivatives as ip antagonists
09/11/2002EP1238973A1 Novel substituted tricyclic compounds
09/11/2002EP1237953A2 Polymerization of olefins
09/11/2002EP1237884A1 Process for the preparation of trans-3-alkyloxy-4-hydroxytetrahydrofuran
09/11/2002EP1237852A1 N-phenylcarbamates having a microbicide, insecticide and acaricide effect
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP1237833A1 Process for the co-production of aliphatic diols and cyclic ethers
09/11/2002EP1237550A2 Methods for treating cell death diseases and inflammation
09/11/2002CN1368968A Method of preparation of maleic anhydride
09/11/2002CN1368961A Compounds for modulation of PPAP gamma activity
09/11/2002CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives
09/11/2002CN1090480C Phenoxy piperazine derivatives for treating disorders of dopamine system
09/10/2002US6448444 Oxime compounds, their use, and intermediates for their production
09/10/2002US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products
09/10/2002US6448416 Electron acceptors for polymeric thin film waveguide media
09/10/2002US6448415 Reacting lactone compound with secondary amine and sulfonyl group containing compound (methanesulfonylchloride); for preparing l-ribose
09/10/2002US6448414 Hydrolytic kinetic resolution of cyclic substrates
09/10/2002US6448408 Process for the preparation of heteroaryl-phenylalanines
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448290 Prostaglandin e2 antagonist or agonist; inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, increasing vesical capacity, cathartic, suppression of gastric acid secretion, antihypertensive, diuretic agents
09/10/2002US6448260 Endothelin receptor antagonists
09/10/2002US6447817 Anti-inflammatory analgesic
09/10/2002US6447748 Benzamide compounds for cancer imaging and therapy
09/06/2002WO2002068402A2 Separation of 2,5-dihydrofuran and water from mixtures thereof by extractive distillation
09/06/2002WO2002068367A1 A method to inhibit ethylene responses in plants
09/06/2002WO2002067929A1 Furan fatty acids for increasing the efficiency of cytostatic treatment and/or radiotherapy
09/06/2002WO2002034697A3 Processes for the preparation of 2-methylfuran and 2-methyltetrahydrofuran
09/06/2002WO2002022577A3 Hydroxamate derivatives useful as deacetylase inhibitors
09/05/2002US20020123636 Hydroxymethylfurfural derived from cellulose contained in lignocellulose solids
09/05/2002US20020123634 Asymmetric derivatives of furamidines; contacting the sample DNA with above compound
09/05/2002US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/05/2002US20020123521 Such as triiodothyroacetic acid, triiodopropionic acid, 4-(2,6-dibromo-4-(1H-tetrazol-5-ylmethyl)-phenoxy)-2-isopropyl-phenol, and 4-(4-hydroxymethyl-2,6-diiodophenoxy)-2-iodo-phenol
09/05/2002DE10109856A1 Use of N-phenyl arylamide for treating or preventing chronic or acute hepatitis B viral infections in humans or animals, including co-infections with hepatitis D virus
09/04/2002EP1236712A1 Amidinophenylpyruvic acid derivative
09/04/2002EP1235820A2 Ether-capped poly(oxyalkylated) alcohol surfactants
09/04/2002EP1235819A1 Method for the preparation of 5-carboxyphthalide
09/04/2002EP1169314B1 Crystalline base of citalopram
09/04/2002EP0746551B1 Optically pure 4-aryl-2-hydroxytetronic acids
09/04/2002CN1367786A Method for preparation of citalopram
09/04/2002CN1367785A Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing substituted phenylenediamine group
09/04/2002CN1090205C Condensed ring azo compound and its producing method and use
09/04/2002CN1090204C Multifunctional cyanate ester and epoxy blends
09/04/2002CN1090171C Process for preparation of monochlorobenzyl by liquid phase air oxidation
09/04/2002CN1090170C Method for producing aromatic carboxylic acid
09/03/2002US6444849 Amide derivatives
09/03/2002US6444840 Bone disorders; vision defects
09/03/2002US6444830 Electron acceptors for polymeric thin film waveguide media
09/03/2002US6444704 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
09/03/2002US6444688 Compounds and compositions with nitrogen-containing non-basic side chains
09/03/2002US6444670 Enzyme inhibitors of protein tyrosine phosphatases; anti-diabetic agents; treatment of insulin resistance associated with obesity, glucose intolerance, diabetes mellitus, hypertension and ischemic diseases of vessels
09/03/2002US6444637 Reaction of alkenes with epoxides, the products thereof and their use as fragrance compounds
09/03/2002US6444606 Supported catalyst system, method for the production and use thereof in olefin polymerization
09/03/2002US6444144 Food, feed, drugs and cosmetics
08/2002
08/29/2002WO2002066453A1 Process for the preparation of citalopram
08/29/2002WO2002066452A1 Processes for producing fluorinated cyclic ethers and use thereof
08/29/2002WO2002066446A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
08/29/2002WO2002066431A1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same
08/29/2002WO2002066418A2 Process for the preparation of arylethanoldiamines useful as agonists of the beta-3-adrenoceptor
08/29/2002WO2002042273A3 Acid derivatives useful as serine protease inhibitors
08/29/2002WO2002040466A3 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders
08/29/2002WO2002015894A3 Use of vitamin d derivatives as bone resorption inhibitors
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease